NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis
USA - NASDAQ:NRC - US6373722023 - Common Stock
15.22 USD
+0.42 (+2.84%)
15.22 USD
0 (0%)
NRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NRC was profitable.
In the past year NRC had a positive cash flow from operations.
In the past 5 years NRC has always been profitable.
In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
NRC has a Return On Assets of 12.68%. This is amongst the best in the industry. NRC outperforms 98.02% of its industry peers.
Looking at the Return On Equity, with a value of 84.06%, NRC belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
With an excellent Return On Invested Capital value of 20.28%, NRC belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.19%.
The last Return On Invested Capital (20.28%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROIC | 20.28% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
NRC has a better Profit Margin (12.78%) than 99.01% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
NRC's Operating Margin of 19.88% is amongst the best of the industry. NRC outperforms 96.04% of its industry peers.
In the last couple of years the Operating Margin of NRC has declined.
NRC has a better Gross Margin (60.31%) than 81.19% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
NRC has less shares outstanding than it did 1 year ago.
NRC has less shares outstanding than it did 5 years ago.
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
NRC has an Altman-Z score of 3.09. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
NRC has a better Altman-Z score (3.09) than 62.38% of its industry peers.
NRC has a debt to FCF ratio of 8.73. This is a slightly negative value and a sign of low solvency as NRC would need 8.73 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.73, NRC is in line with its industry, outperforming 54.46% of the companies in the same industry.
NRC has a Debt/Equity ratio of 3.61. This is a high value indicating a heavy dependency on external financing.
NRC has a worse Debt to Equity ratio (3.61) than 77.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Altman-Z | 3.09 |
ROIC/WACC2.39
WACC8.48%
2.3 Liquidity
NRC has a Current Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.70, NRC is not doing good in the industry: 86.14% of the companies in the same industry are doing better.
NRC has a Quick Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NRC (0.70) is worse than 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.26%.
Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -4.08% in the last year.
The Revenue has been growing slightly by 2.25% on average over the past years.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.77, the valuation of NRC can be described as rather expensive.
Based on the Price/Earnings ratio, NRC is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
NRC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.77 | ||
| Fwd PE | N/A |
4.2 Price Multiples
65.35% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
NRC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.85 | ||
| EV/EBITDA | 12.18 |
4.3 Compensation for Growth
The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.02%, NRC has a reasonable but not impressive dividend return.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.48. NRC pays more dividend than 95.05% of the companies in the same industry.
NRC's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.02% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
62.38% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
NRC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP62.38%
EPS Next 2YN/A
EPS Next 3YN/A
15.22
+0.42 (+2.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.59%
Inst Owner Change0.23%
Ins Owners9.49%
Ins Owner Change10.89%
Market Cap350.97M
Analysts45
Price TargetN/A
Short Float %3.05%
Short Ratio3.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.02% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.77 | ||
| Fwd PE | N/A | ||
| P/S | 2.5 | ||
| P/FCF | 37.85 | ||
| P/OCF | 16.47 | ||
| P/B | 16.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.18 |
EPS(TTM)0.77
EY5.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY2.64%
OCF(TTM)0.92
OCFY6.07%
SpS6.08
BVpS0.92
TBVpS-2.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROCE | 26.45% | ||
| ROIC | 20.28% | ||
| ROICexc | 21.34% | ||
| ROICexgc | 67.64% | ||
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% | ||
| FCFM | 6.61% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 189.66% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 9.03 | ||
| Cash Conversion | 62.23% | ||
| Profit Quality | 51.72% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 3.09 |
F-Score5
WACC8.48%
ROIC/WACC2.39
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.39%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-38.68%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%